Alan Moses - Articles and news items

Novo Nordisk Logo

Combination insulin degludec/insulin aspart significantly reduced hypoglycaemia in diabetes patients

Industry news, News / 6 December 2011 / Novo Nordisk

Insulin degludec / insulin aspart reduced rates of hypoglycaemia by 58%…

Novo Nordisk Logo

Positive opinion on the usage of Levemir® (insulin detemir) as add-on therapy to Victoza® (liraglutide) in people with type 2 diabetes

Industry news, News / 23 September 2011 / Novo Nordisk

CHMP has adopted a positive opinion on the usage of Novo Nordisk’s basal insulin analogue, Levemir®…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+